Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow
Canadian Respiratory Journal · 22.03.2024 · 2024 · 1-8
DOI: 10.1155/2024/8034923 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Respiratory Journal, erschienen am 22.03.2024. Verfasst von Jill A Ohar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pulmonary, Critical Care, Allergy, and Immunologic Diseases, Wake Forest School of Medicine, Winston-Salem, NC, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Theravance Biopharma Ireland Limited, Mylan, Theravance Biopharma US.
Themen: COPD
Abstract (Originalsprache)
Introduction
Many patients with chronic obstructive pulmonary disease (COPD) may derive inadequate benefit from dry powder inhalers (DPIs) because of suboptimal peak inspiratory flow (sPIF).
Objectives
To assess the clinical burden of COPD by characterizing the clinical characteristics of participants with sPIF against medium-low resistance DPIs versus those with optimal PIF (oPIF) from two phase 3 clinical trials.
Methods
Baseline data were collected from two randomized, controlled, phase 3 trials (NCT03095456; NCT02518139) in participants with moderate-to-severe COPD. oPIF (60 L/min) against the medium-low resistance DPIs was used as the threshold for defining the PIF subgroups (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Section of Pulmonary, Critical Care, Allergy, and Immunologic Diseases, Wake Forest School of Medicine, Winston-Salem, NC, USA.
- Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
- Valley Regional Hospital, Claremont, NH, USA.
- Theravance Biopharma US, Inc., South San Francisco, CA, USA.
ORCID-Profile: Edmund J Moran, Glenn D Crater
Förderung
- Theravance Biopharma Ireland Limited
- Mylan
- Theravance Biopharma US
Zitieren
APA
Ohar, J. A., Mahler, D. A., Davis, G. N., Lombardi, D. A., Moran, E. J., & Crater, G. D. (2024). Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow. Canadian Respiratory Journal, 2024, 1-8. https://doi.org/10.1155/2024/8034923
Vancouver
Ohar JA, Mahler DA, Davis GN, Lombardi DA, Moran EJ, Crater GD. Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow. Canadian Respiratory Journal. 2024;2024:1-8. doi:10.1155/2024/8034923
BibTeX
@article{Ohar2024,
author = {Ohar, Jill A and Mahler, Donald A and Davis, Gabrielle N and Lombardi, David A and Moran, Edmund J and Crater, Glenn D},
title = {Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow},
journal = {Canadian Respiratory Journal},
year = {2024},
volume = {2024},
pages = {1--8},
doi = {10.1155/2024/8034923}
}
EUVIMED